SG10202103987QA - Il-12 Compositions And Methods Of Use In Hematopoietic Recovery - Google Patents
Il-12 Compositions And Methods Of Use In Hematopoietic RecoveryInfo
- Publication number
- SG10202103987QA SG10202103987QA SG10202103987QA SG10202103987QA SG10202103987QA SG 10202103987Q A SG10202103987Q A SG 10202103987QA SG 10202103987Q A SG10202103987Q A SG 10202103987QA SG 10202103987Q A SG10202103987Q A SG 10202103987QA SG 10202103987Q A SG10202103987Q A SG 10202103987QA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- hematopoietic recovery
- hematopoietic
- recovery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462073197P | 2014-10-31 | 2014-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202103987QA true SG10202103987QA (en) | 2021-05-28 |
Family
ID=55851468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703515YA SG11201703515YA (en) | 2014-10-31 | 2015-10-30 | Il-12 compositions and methdos of use in hematopoietic recovery |
| SG10202103987QA SG10202103987QA (en) | 2014-10-31 | 2015-10-30 | Il-12 Compositions And Methods Of Use In Hematopoietic Recovery |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703515YA SG11201703515YA (en) | 2014-10-31 | 2015-10-30 | Il-12 compositions and methdos of use in hematopoietic recovery |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20160120948A1 (en) |
| EP (1) | EP3212214A4 (en) |
| JP (1) | JP2017533278A (en) |
| KR (1) | KR20170086052A (en) |
| CN (1) | CN107206055A (en) |
| AU (2) | AU2015338995A1 (en) |
| CA (1) | CA2966217A1 (en) |
| IL (1) | IL251957A0 (en) |
| SG (2) | SG11201703515YA (en) |
| WO (1) | WO2016070072A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022040628A1 (en) * | 2020-08-21 | 2022-02-24 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Combination therapy comprising her-2-dc1 vaccine, a probiotic, and semaphorin |
| CN114887034B (en) * | 2022-07-14 | 2022-10-28 | 中山莱博瑞辰生物医药有限公司 | Use of LLP2A-Ale for the preparation of a medicament for the treatment and/or prevention of peripheral blood lymphopenia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7939058B2 (en) * | 2003-07-03 | 2011-05-10 | University Of Southern California | Uses of IL-12 in hematopoiesis |
| CN100518817C (en) * | 2003-07-04 | 2009-07-29 | 南加州大学 | Therapeutic agent to recover hematopoiesis function and its compositions and usage |
| US20090047241A1 (en) * | 2007-06-20 | 2009-02-19 | University Of Southern California | Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation |
| WO2011146574A1 (en) * | 2010-05-18 | 2011-11-24 | Neumedicines, Inc. | Il-12 formulations for enhancing hematopoiesis |
| EP2804620A4 (en) * | 2012-01-18 | 2016-04-13 | Neumedicines Inc | Il-12 for radiation protection and radiation-induced toxicity mitigation |
| WO2014160318A1 (en) * | 2013-03-13 | 2014-10-02 | Neumedicines, Inc. | Endogenous vaccine for cancer and infectious diseases |
-
2015
- 2015-10-30 US US14/928,439 patent/US20160120948A1/en not_active Abandoned
- 2015-10-30 KR KR1020177014517A patent/KR20170086052A/en not_active IP Right Cessation
- 2015-10-30 EP EP15853989.0A patent/EP3212214A4/en not_active Withdrawn
- 2015-10-30 SG SG11201703515YA patent/SG11201703515YA/en unknown
- 2015-10-30 JP JP2017542805A patent/JP2017533278A/en active Pending
- 2015-10-30 WO PCT/US2015/058355 patent/WO2016070072A1/en active Application Filing
- 2015-10-30 CN CN201580071432.4A patent/CN107206055A/en active Pending
- 2015-10-30 AU AU2015338995A patent/AU2015338995A1/en not_active Abandoned
- 2015-10-30 CA CA2966217A patent/CA2966217A1/en active Pending
- 2015-10-30 SG SG10202103987QA patent/SG10202103987QA/en unknown
-
2017
- 2017-04-26 IL IL251957A patent/IL251957A0/en unknown
-
2019
- 2019-03-04 US US16/291,999 patent/US20200030412A1/en not_active Abandoned
-
2021
- 2021-07-06 US US17/368,346 patent/US20220168393A1/en active Pending
- 2021-08-11 AU AU2021215168A patent/AU2021215168A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170086052A (en) | 2017-07-25 |
| EP3212214A1 (en) | 2017-09-06 |
| AU2021215168A1 (en) | 2021-09-02 |
| US20200030412A1 (en) | 2020-01-30 |
| CA2966217A1 (en) | 2016-05-06 |
| CN107206055A (en) | 2017-09-26 |
| EP3212214A4 (en) | 2018-07-11 |
| WO2016070072A1 (en) | 2016-05-06 |
| US20220168393A1 (en) | 2022-06-02 |
| SG11201703515YA (en) | 2017-05-30 |
| IL251957A0 (en) | 2017-06-29 |
| JP2017533278A (en) | 2017-11-09 |
| US20160120948A1 (en) | 2016-05-05 |
| AU2015338995A1 (en) | 2017-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258041A1 (en) | Immune cell compositions and methods of use | |
| HRP20192145T1 (en) | Carrier-antibody compositions and methods of making and using the same | |
| HK1247238B (en) | Engineered crispr-cas9 compositions and methods of use | |
| HK1244841A1 (en) | Methods and compositions for selectively eliminating cells of interest | |
| IL251576A0 (en) | Methods and compositions for generating or maintaining pluripotent cells | |
| GB2535253B (en) | Compositions and methods | |
| ZA201900225B (en) | Methods and compositions for gene expression in plants | |
| ZA201703443B (en) | Oral rehydration composition and methods thereof | |
| ZA201701909B (en) | Trichoderma compositions and methods of use | |
| GB201417828D0 (en) | New methods and compositions | |
| HK1243334A1 (en) | Compositions and methods of stimulating and expanding t cells | |
| HK1231395A1 (en) | Bioactive heme-haloperoxidase compositions and methods of their use | |
| EP3433035A4 (en) | Compositions and methods of use thereof in sandcasting | |
| PL3233233T3 (en) | Defoaming compositions comprising amphiphilic particles and methods of using the same | |
| HK1243404A1 (en) | Tryptamide compositions and methods of use | |
| IL251957A0 (en) | Il-12 compositions and methods of use in hematopoietic recovery | |
| IL261794A (en) | Compositions and methods of their use | |
| GB2537518B (en) | Settable compositions and methods of use | |
| GB201402915D0 (en) | Compositions and methods | |
| GB201403212D0 (en) | Compositions and methods |